Brockhoff, M., Rion, N., Chojnowska, K., Wiktorowicz, T., Eickhorst, C., Erne, B., . . . Castets, P. (2017). Targeting deregulated AMPK/mTORC1 pathways improves muscle function in myotonic dystrophy type I. J Clin Invest.
Citação norma ChicagoBrockhoff, Marielle, et al. "Targeting Deregulated AMPK/mTORC1 Pathways Improves Muscle Function in Myotonic Dystrophy Type I." J Clin Invest 2017.
MLA citiranjeBrockhoff, Marielle, et al. "Targeting Deregulated AMPK/mTORC1 Pathways Improves Muscle Function in Myotonic Dystrophy Type I." J Clin Invest 2017.
Opozorilo: Ti citati niso vedno 100% točni.